Back to News
Market Impact: 0.3
Eli Lilly Sells 53% More at Lower Prices: Rapid Earnings Reaction
Source: fool.com
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Eli Lilly's third-quarter revenue rose 39% to about $24.4 billion, as volume increased 53% and more than offset a 15% decline in realized prices. The article says part of the quarter's revenue will not recur and deal charges are weighing on earnings, but provides no earnings figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
0.10
Ticker Sentiment
LLY0.45
More News
- Alphabet’s stock has worst day in over 20 years, dragging the S&P 500 to first loss in four days
- We're raising our price target on Eli Lilly as the obesity-drug boom rolls on
- West Pharma earnings show it's more than a GLP-1 play. Why we see more upside
- Lilly’s obesity drug strength fuels record rally, Wall Street optimism
- Nasdaq futures slide as mixed Big Tech results test AI trade
- Stocks making the biggest moves midday: ADT, Alphabet, Caterpillar, Eli Lilly, Chipotle & more